Biotech Investment
Funding rounds, deals, M&A and the money moving the sector.
Latest Biotech Investment news
South Korea's KOSDAQ Biotech Listed Companies Flood Market as Management Rights Go Up for Sale Amid Stock Plunges and Cash Crunch
Read at BigGo Finance →Migraine biotech TriGemX to go public via SPAC merger with $246M in proceeds
Read at Dealroom →Investment firm TCGX picks migraine biotech TriGemX to take public via SPAC
Read at Fierce Biotech →China moves to restrict foreign biotech acquisitions
Read at STAT →Germany’s Medical Biotechnology Sector is Flourishing
Read at PharmTech.com →TriGemX Bio is going public through SPAC to get its migraine prospect to market
Read at Endpoints News →From the knowledge base
ASHG: Long-Read Genomics Meets Clinical Data in PacBio, Verily Health AI Deal
A multi-year collaboration will connect PacBio's HiFi sequencing with Verily Pre, combining long-read genomic and clinical data for biomedical research and AI model development.
5 iced coffees we're bringing to a job interview
A viral post sparked debate around the professionalism of iced coffee. Explore the gallery for our five natural iced coffee picks sure to impress.
It will take more than data to improve traceability in the cotton supply chain
New research supported by Cotton Diaries explores the idea of "relational traceability" and making farmers a key source of intel.
Former MIT professor David Sabatini awarded $6M in defamation case
A Massachusetts jury awarded $6 million in damages to prominent biologist David Sabatini, years after sexual harassment allegations led to his ouster from MIT. Roughly five years ago, Sabatini brought the
How this plastic-free personal care brand tackles men's reproductive health
Learn about Old Salt Grooming's plastic-free product line paired with broader messaging around men's reproductive health and the environmental cost of personal care.
Antheia gets $80M conditional DOD loan to onshore to the US
Biosynthesis manufacturer Antheia has won a conditional loan of $80 million from the US Department of Defense to help boost the domestic production of generic drugs. "Over time, we aim to manufacture Antheia's full pipeline ...